Skip to main content
Clinical Trials/NCT01443312
NCT01443312
Completed
Not Applicable

Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia

HaEmek Medical Center, Israel1 site in 1 country28 target enrollmentOctober 2011
ConditionsThalassemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thalassemia
Sponsor
HaEmek Medical Center, Israel
Enrollment
28
Locations
1
Primary Endpoint
The characteristics of patients with thalassemia intermedia
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The definition of Thalassemia Intermedia is not generally accepted and the specific clinical and laboratory characteristics varies between patients. Some patients are blood transfusion dependent and others are occasionally transfused. Also the mutations in the beta globin gene are diverse. Another mutations including mutations in the alfa globin gene and in the xmn1 gene can affect the clinical course of this disease. The purpose of this study is to summarize the characteristics of patients with Thalassemia Intermedia treated at the Pediatric Hematology Unit at the HaEmek Medical Center in Israel

Detailed Description

The characteristics that will be recorded from the medical files include: demographic data, included gender and ethnic origin, family history, age at diagnosis, number and frequency of blood transfusions including age of first transfusion and physical examination findings. The laboratory data included iron metabolism parameters, mutation in the alfa and beta gene and the presence of the xmn1 polymorphism.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
December 2014
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr Koren Ariel

Head of Pediatric Dpt B and Pediatric Hematology Unit

HaEmek Medical Center, Israel

Eligibility Criteria

Inclusion Criteria

  • All patients treated at the Pediatric Hematology Unit

Exclusion Criteria

  • Not enough medical records.
  • Patients who refuse to give consent to perform genetic studies will be included in the study but only the retrospective clinical data will be recorded.

Outcomes

Primary Outcomes

The characteristics of patients with thalassemia intermedia

Time Frame: One year

Observational study that analyzed the characteristics of thalassemia intermedia patients

Study Sites (1)

Loading locations...

Similar Trials